Table 1.
Characteristics of the included studies.
| Study | Sample E/C |
Experiment | control | Acupoints | Intervention time | Outcomes | AE |
|---|---|---|---|---|---|---|---|
| Liu 2006 [10] | 44/44 | ACE | Medicine | PC6, SP6, CV4, CV17, LR3 | 15 days before MS | IR | NR |
|
| |||||||
| Xu 2005 [11] | 54/48 | AI+AT | Medicine | AI in SP6, ST36 and AT in L14, LR6, RN4, RN6, EX-HN5 | 10 days before MS | IR | NR |
|
| |||||||
| Fang 2008 [12] | 47/43 | AT | Medicine | DU24, LR3+L14, SP6 | 14-16 days before MS | IR, symptom score, HAMA score | NR |
|
| |||||||
| Li 2011 [13] | 15/15 | AT | Medicine | RN12, RN10, RN4, RN6, SP15, ST29 | 7 days before MS | symptom score, SCL-90 scores, IR | NR |
|
| |||||||
| Yu 2006 [14] | 33/32 | AT | sham AT | DU20, EX-HN3, EX-HN5, SP6, SP10 | 7 days before MS | symptom score Uncomfortable Days IR |
hypomenorrhea |
|
| |||||||
| Zhang 2017 [15] | 30/30/30 | AT | Medicine/ACE+Auricular points | LR3, SP6, PC6, LA14, BL18 | 14 days before MS | symptom score SCL-90 score IR, E2, P |
NR |
|
| |||||||
| Hong 2002 [16] | 35/31 | EA | Medicine | Scalp acupuncture: Frontal line, middle line of vertex | three times per week | symptom score, IR | NR |
|
| |||||||
| Xu 2006 [17] | 30/30 | AT | Medicine | DU8, DU6, DU4, BL18, BL20, BL22, BL47, BL49, BL51 | 14 days before MS | IR | NR |
|
| |||||||
| Sun 2004 [18] | 30/31 | AT | Medicine | D20, RN17, RN4, SP6, PC6, LR3 | 14 days before MS | symptom score, IR | NR |
|
| |||||||
| Xu 2008 [19] | 100/100 | AT | Medicine | GB20, DU15 | When the symptoms occurred | IR | NR |
|
| |||||||
| Zhang 2016 [20] | 35/35/35 | AT+Intradermal needle | non acupoint superficial AT sham AT |
AT:DU8, EX-HN3, RN12, RN10, BL24, RN4, EX-CA1, SP6, KI6, LI4, LR3 Intradermal needle:BL15, BL18, BL23 |
AT:3 per week Intradermal needle:2 times per week |
HAMA/WHOQOL-BREF/DRSP scale IR |
Hematoma, pain;redness, itching, in the skin, pain |
|
| |||||||
| Zeng 2013 [21] | 80/80 | AT+Medicine | Medicine | LR3, K13, RN6, BL18, RN17, SP6 | 10 days before MS | IR | NR |
|
| |||||||
| Habek 2002 [22] | 18/17 | AT | sham AT | DU20, L14, LR3, RN3, RN4, RN6, PC6, GB34, BL23 | Luteal phase | IR | Hematoma |
|
| |||||||
| Shin 2009 [23] | 10/10/10 | Korea hand AT | no treatment | A5, A6, A8, A12, A16, A18, N18, F6 | 1 per 3 days | symptom score | None |
|
| |||||||
| Kim 2005 [24] | 10/10 | AT | sham AT | SP6, RN9 | 2 per week | symptom score | NR |
(ACE: acupuncture catgut embedding, A/C: acupuncture group versus control group, AE: adverse events, AI: acupoint injection, AT: acupuncture, DRSP score: Daily record of severity of problems scale, E2: estradiol, ET: electroacupuncture, HAMA: Hamilton anxiety scale, IR: effective rate, MS: menstruation, NR: not reported, P: progesterone, SCL-90: SymptomChecklist90, WHOQOL-BREF scale:WHO Quality of Life-BREF scale)